Fact CheckerSign in

NCT07670845Not yet recruiting

Implementation of an Encounter-based Patient Decision Aid for Heart Failure Medications in Heart Function Clinics: the SHARE-HF Pragmatic, Stepped-wedge Trial

Source: ClinicalTrials.gov · Last updated 26 Jun 2026

Brief summary (registry, in English)

The goal of this clinical trial is to learn if a shared decision-making tool called SHARE-HF can help more people with heart failure receive guideline-recommended medications. The study includes adults with a type of heart failure called heart failure with reduced ejection fraction (HFrEF), who attend heart function clinics in British Columbia, Canada. The main question it aims to answer is: \- Does use of SHARE-HF during clinic visits lead to more participants receiving their recommended heart failure medications after 6 months? Researchers will compare clinics using the SHARE-HF tool to clinics providing usual care to see if the tool helps more participants get their recommended medications. Participants will use the SHARE-HF web-based tool with their clinician during regular clinic visits. The tool shows participants how their heart failure may affect their health over time, explains their medication options, and helps them and their clinician make treatment decisions together.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
1350 (estimated)
First submitted
17 Jun 2026
Start date
2 Nov 2026
Primary completion date
30 Apr 2028
Lead sponsor
University of British Columbia
NCT number
NCT07670845

What you commit to

  • Study type: Interventional
  • Planned participants: 1350
  • From 2 Nov 2026 to the primary completion date, 30 Apr 2028
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous request to the clinic not to be contacted for research;
  • Receiving palliative care;

Lab values

  • End-stage kidney disease on dialysis or latest estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73 m2.

Other

  • Consent opt-out;
  • Non-BC residents;
  • Residents of long-term care facilities or hospice;

Who the study is looking for

  • Patient in a participating HF clinic;
  • In-person initial HF clinic visit;
  • Age 40-85 years;
  • Heart failure with reduced ejection fraction (HFrEF), as indicated by latest cardiac imaging demonstrating ejection fraction ≤40%.

Age in the registry: 40 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.